Impel NeuroPharma Inc.

NASDAQ:IMPL   3:59:56 PM EDT
8.31
-0.93 (-10.06%)
Earnings Announcements

Impel Neuropharma Announces First Quarter 2021 Financial Results And Provides Business Update

Published: 06/07/2021 13:03 GMT
Impel NeuroPharma Inc. (IMPL) - Impel Neuropharma Announces First Quarter 2021 Financial Results and Provides Business Update.
Q1 GAAP Loss per Share $15.09.
Non-GAAP Net Loss per Share Was $0.54 for Q1 of 2021.
Revenue is expected to be $1.66 Million
Adjusted EPS is expected to be -$0.86

Next Quarter Revenue Guidance is expected to be $3.7 Million
Next Quarter EPS Guidance is expected to be -$0.90

More details on our Analysts Page.